Valeant Pharmaceuticals International Inc. (VRX, VRX.TO) announced the completion of its acquisition of Medicis Pharmaceutical Corp. (MRX) following the approval of the transaction by stockholders of Medicis at the special meeting held on December 7, 2012.
Canada-based Valeant in September agreed to buy Medicis for $44 per share, or a total of about $2.6 billion.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.